Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
The maturation of the B-cell receptor (BCR) repertoire is a cornerstone of adaptive immunity, culminating in the production of high-affinity antibodies that are critical for pathogen neutralization and immunological memory. Central to this process is somatic hypermutation (SHM), a sophisticated mechanism that introduces point mutations into the variable (V) regions of immunoglobulin (Ig) genes at a rate approximately one million times higher than the background genomic mutation rate.
| Features | Description |
| Mutation Rate | ~10⁶ times higher than baseline genomic mutation rate. |
| Targeting Bias |
|
| Enzyme Involved | Activation-Induced Deaminase (AID). |
| Outcome | Generating a vast pool of BCR variants, from which B cells with enhanced antigen-binding affinity are positively selected and clonally expanded—a process termed affinity maturation. |
Despite its recognized importance, a precise and comprehensive understanding of the intrinsic patterns of SHM has remained elusive. In any physiological immune response, the observed mutation patterns are shaped by two forces:
| Component | Role in SHM Patterns |
| Intrinsic biochemical biases | Dictated by SHM machinery (e.g., hotspot targeting, mutation frequency). |
| Antigen-driven selection | Filters B cells by antigen-binding fitness, masking intrinsic patterns. |
Disentangling these two components is paramount, as alterations in intrinsic SHM processes (such as shifts in hotspot usage) are increasingly implicated in diseases ranging from B-cell malignancies to autoimmune disorders.
To address these gaps, Creative Biolabs' BCR Repertoire Profiling Service for SHM Pattern Analysis enables:
Uncover the Hidden Patterns of SHM. .
Our platform is designed to provide an end-to-end solution, from biological sample to actionable data, ensuring the highest standards of accuracy, resolution, and reproducibility.
The cornerstone of our platform is the subsequent deployment of our "Next-generation SHM targeting models." These are advanced, custom-developed algorithms that analyze the quality-controlled, full-length V-gene sequences to quantitatively characterize the intrinsic features of SHM.
Scalable infrastructure capable of processing large-scale BCR repertoire datasets, enabling statistically robust analyses.
Sequencing and analytical protocols designed to capture the entire Ig V-gene, preventing the loss of contextual information inherent in short-read or partial-gene approaches.
Implementation of a bespoke sequencing error model to ensure high accuracy in mutation identification.
Utilization of exclusive, internally developed computational models for in-depth, quantitative analysis of SHM hotspot and coldspot motifs, including the discovery of novel patterns.
Turn Complex Mutation Data into Clear Biological Insights. .
The BCR Repertoire Profiling Service for SHM Pattern Analysis is a comprehensive offering that delivers a high-resolution, quantitative characterization of the intrinsic mutational biases of SHM. Our service is structured as a standardized, four-step process meticulously designed to eliminate confounding variables and produce data of the highest scientific integrity.
The service begins with the targeted isolation of B-cell populations whose mutational patterns have not been sculpted by antigen-driven selection. The choice of cell population is critical and tailored to the specific research question, but often involves precursor B cells or other specific subsets known to reflect the unbiased output of the SHM process. This step is fundamental to our ability to provide a true baseline of SHM activity.
Decode the Blueprint of Immunity with Confidence. .
The data and insights generated by our SHM Pattern Analysis service have profound implications for both basic immunological research and translational clinical studies.
In Basic Immunology Research:
Our high-resolution data provides an unprecedented view of the SHM landscape, enabling researchers to validate, refine, or challenge existing hypotheses regarding the molecular mechanisms of AID targeting and DNA repair pathways.
The service can be used to compare intrinsic SHM patterns across different species, strains, or physiological states (e.g., aging, infection). This allows for investigation into how genetic background or environmental factors influence the fundamental properties of the SHM process.
By providing a clear baseline of mutational bias, our service enables researchers to precisely quantify the contribution of selection pressure versus intrinsic mutational propensity in shaping the final antibody repertoire during an immune response.
In Clinical and Translational Research:
Certain pathologies, including B-cell lymphomas and autoimmune diseases, are hypothesized to involve dysregulation of the SHM machinery. Our service allows for a direct comparison of intrinsic SHM patterns between patient cohorts and healthy controls, potentially uncovering novel disease biomarkers or therapeutic targets related to aberrant SHM.
In the context of cancer immunotherapy or vaccine development, monitoring the SHM patterns in responding B cells can provide critical insights into the quality and effectiveness of the induced immune response. For example, analysis can determine whether SHM is activated appropriately and whether affinity maturation is proceeding efficiently post-treatment.
From Raw Repertoire Data to Breakthrough Discoveries — .
Unlike traditional methods that analyze only fragments, our approach encompasses the entire V-gene. This comprehensive coverage is critical for accurate modeling, as it preserves the local and regional sequence context that influences SHM targeting, revealing a complete and unbiased map of hotspots and coldspots.
We employ sophisticated, internally developed computational models that extend far beyond the analysis of simple, canonical motifs. These models are capable of discovering novel, highly mutable sequence contexts, providing a deeper and more accurate characterization of SHM biases.
Our methodology is fundamentally designed around the principle of analyzing SHM in a selection-free context. Through meticulous experimental design and cell sorting, we isolate the intrinsic properties of the mutational machinery, providing a "pure" dataset that is essential for studying the underlying mechanisms of SHM and its dysregulation in disease.
The entire service is supported by our advanced sequencing and bioinformatics infrastructure. This allows us to handle large-scale projects, ensuring that the resulting analyses are not limited by sample size and possess the statistical power required for robust and reliable conclusions.
Explore Intrinsic SHM Mechanisms Like Never Before. .
Empower Your Immunology Research with High-Resolution SHM Profiling. .
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
